Trans-Trimethoxyresveratrol (trans-trismethoxy Resveratrol, (E)-Resveratrol trimethyl ether, trans-3,5,4-Trimethoxystilbene) is an orally active natural derivative of Resveratrol (HY-16561). Trans-Trimethoxyresveratrol has an enhanced anticancer profile compared to Resveratrol, exhibiting higher potency than resveratrol, with improved cancer cell proliferation inhibition, induction of cell cycle arrest, decreased metastasis, and increased apoptosis. Trans-Trimethoxyresveratrol causes microtubule disassembling and tubulin depolymerization and exerts anti-angiogenic effects through VEGFR2. Trans-Trimethoxyresveratrol can be used for the studies of anti-angiogenic and anti-cancer (such as non-small cell lung cancer and osteosarcoma)[1][2][3][4][5][6].
Molecular Weight:
270.32
Purity:
99.35
CAS Number:
[22255-22-7]
Formula:
C17H18O3
Target:
Apoptosis,Caspase,Reactive Oxygen Species (ROS),VEGFR
Application Notes:
MCE Product type: Natural Products
* VAT and and shipping costs not included. Errors and price changes excepted